SCHEMBL4394396

SCHEMBL4394396

CN1CCc2c(-c3ccc(S(=O)(=O)N(C)C)cc3)ccc(N)c2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.47
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR2C P28335 3/20 0.36
HTR2A P28223 2/20 0.36
GRIA1 P42261 1/20 0.35
GRIA2 P42262 1/20 0.35
GRIA3 P42263 1/20 0.35
GRIA4 P48058 1/20 0.35
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
PTK2 Q05397 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTR2B P41595 1/20 0.35
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8141015 0.81 ALDH1A1 (0.39) HTR6ALDH1A1HTR2CHTR2AHTT
SCHEMBL8142621 0.79 CYP3A4 (0.43) ALDH1A1MEN1KMT2AGRIA1GRIA2
SCHEMBL13592435 0.79 GRIA1 (0.34) ALDH1A1MEN1KMT2AGRIA1GRIA2
SCHEMBL6611465 0.79 HDAC1 (0.38)
Hydrochloric Acid SCHEMBL4377355 0.78 MEN1 (0.41) HTR6MEN1POLBKMT2AHTR2C
Hydrochloric Acid SCHEMBL6613546 0.77 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AHTR2ALMNA
SCHEMBL13591024 0.76 HTR6 (0.40) HTR6ALDH1A1MEN1PKMKMT2A
SCHEMBL6612849 0.75 HTR6 (0.46) HTR6ALDH1A1MEN1POLBKMT2A
SCHEMBL6608100 0.75 HRH4 (0.39) HTR6GRIA1GRIA2GRIA3GRIA4
SCHEMBL4370479 0.75 HTR6 (0.47) HTR6ALDH1A1MEN1KMT2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632948-B2 Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives NEUROSEARCH A/S (DK) 2009-12-15 US claimed
US-20060178391-A1 Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives NEUROSEARCH A/S (DK) 2006-08-10 US claimed
EP-1532146-B1 A METHOD OF PREPARING ENANTIOMERS OF INDOLE-2,3-DIONE-3-OXIME DERIVATIVES NEUROSEARCH AS (DK) 2006-03-01 EP claimed
US-7632948-B2 Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives NEUROSEARCH A/S (DK) 2009-12-15 US disclosed
US-7632948-B2 Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives NEUROSEARCH A/S (DK) 2009-12-15 US disclosed
US-20060178391-A1 Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives NEUROSEARCH A/S (DK) 2006-08-10 US disclosed
EP-1532146-B1 A METHOD OF PREPARING ENANTIOMERS OF INDOLE-2,3-DIONE-3-OXIME DERIVATIVES NEUROSEARCH AS (DK) 2006-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178391-A1 Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives IDO2, IDO1, TPH2 HTR6 62/4885ALDH1A1 694/4885MEN1 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.